Virothera

Virothera develops gene therapies intended to regulate immune responses in persistent diseases.

Its approach draws on human versions of immune-modifying proteins that viruses have evolved to influence immune cells. The company aims to use these proteins to create targeted treatments with potential advantages over some cell- and antibody-based approaches.

Its research programmes cover infectious diseases, cancer and autoimmune disorders, with work focused on immune regulation.